Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 33342-521

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 33342-521). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diltiazem-120-mg-30.jpg (Diltiazem 120 mg 30)

This product is a capsule containing Diltiazem Hydrochloride equivalent to 1103 mg diltiazem. The dosage stated is 120mg, and it is indicated for once-a-day usage. It is extended-release and designed for resistance to pH changes. The manufacturer is Macleods Pharma USA, Inc., based in Princeton, NJ. The capsules are produced by Macleods Pharmaceuticals Ltd. in Baddi, Himachal Pradesh, India. The product should be stored between 15° to 30°C (59" to B6°F) and protected from excessive humidity. Additionally, the package insert should be consulted for prescribing information, and it is essential to keep the medication out of reach of children.*

FDA Label Image

Diltiazem-120-mg-90.jpg (Diltiazem 120 mg 90)

This text appears to be a description of Hydrochloride Extended-Release Capsules containing Diltiazem Hydrochloride, each capsule having a dosage of 120 mg. The capsules are intended for use according to the package insert for prescribing information. The product is to be stored between 20°C to 25°C and protected from excessive humidity. It is manufactured by Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd in India. A warning emphasized keeping these capsules out of reach of children.*

FDA Label Image

Diltiazem-120-mg-cartons.jpg (Diltiazem 120 mg Cartons)

FDA Label Image

Diltiazem-180-mg-30.jpg (Diltiazem 180 mg 30)

Each capsule contains Diliazem Hydrochloride, USP 180 mg, equivalent to 165.45 mg of diliazem. Usual dosage can be found in the package insert. Keep out of reach of children. Store at 20° to 25°C (66° to 77°F). Manufacturing information is shown for reference.*

FDA Label Image

Diltiazem-180-mg-90.jpg (Diltiazem 180 mg 90)

The text is a label for Diltiazem Hydrochloride Extended-Release Capsules, USP, containing 180 mg each. The medication is meant for once-a-day dosage. It is important to store the capsules between 20°C to 25°C (68°F to 77°F) and away from children. The product is manufactured by Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd in India. The text advises consulting the package insert for detailed prescribing information and warns to keep the capsules in a light-resistant and tight container to avoid excessive humidity.*

FDA Label Image

Diltiazem-180-mg-cartons.jpg (Diltiazem 180 mg Cartons)

This is a description of a medication package containing Diltiazem Hydrochloride Extended-Release Capsules, USP at a strength of 180 mg. The package includes a warning to keep it away from children and instructions to store it at temperatures between 20°C to 25°C. The dosage instructions recommend taking only 6 capsules as a once-a-day dosage. The medication is manufactured by Macleods Pharma USA and Macleods Pharmaceuticals in India. It also mentions to refer to the package insert for prescribing information.*

FDA Label Image

Diltiazem-240-mg-30.jpg (Diltiazem 240 mg 30)

This text provides information about Diltiazem Hydrochloride extended-release capsules, each containing 240mg equivalent to 220.6 mg of diltiazem. The usual dosage instructions are advised to be checked in the package insert. A warning to keep the medication out of reach of children is included. The capsules are manufactured for Macleods Pharma USA, Inc. and should be stored in a light-resistant, tight container at 20° to 25°C with permissible excursions between 15° to 30°C. It is recommended to avoid excessive humidity. The manufacturer's information indicates Macleods Pharmaceuticals Ltd. in Baddi, Himachal Pradesh, India.*

FDA Label Image

Diltiazem-240-mg-90.jpg (Diltiazem 240 mg 90)

Each capsule contains Diltiazem Hydrochloride, USP 240 mg. The usual dosage is for extended-release capsules. Store in a cool, dry place between 20° to 25°C (68° to 77°F) with child-resistant closures. Avoid excessive humidity. Manufactured by Macleods Pharma USA, Inc. for Macleods Pharmaceuticals Ltd. Each pack contains 90 capsules in Princeton, NJ, USA and Baddi, Himachal Pradesh, INDIA.*

FDA Label Image

Diltiazem-240-mg-cartons.jpg (Diltiazem 240 mg Cartons)

FDA Label Image

Diltiazem-300-mg-30.jpg (Diltiazem 300 mg 30)

This is a medication label for Diltiazem Hydrochloride extended-release capsules. Each capsule contains 300 mg of Diltiazem Hydrochloride. The usual dosage is 300 mg. The medication should be stored between 20°C to 25°C (68°F to 77°F) with excursions between 15°C to 30°C (59°F to 86°F) allowed. The manufacturer is Macleods Pharma USA, Inc. and the product is manufactured in Baddi, Himachal Pradesh, India.*

FDA Label Image

Diltiazem-300-mg-90.jpg (Diltiazem 300 mg 90)

This is a product description for Diltiazem Hydrochloride capsules, each containing 300 mg of the active ingredient. It is an extended-release medication to be taken once a day and stored at temperatures between 20° to 25°C. The capsules are light-resistant, in a tightly sealed container with child-resistant closure. Manufactured by Waclonds Pharma USA, Inc., each box contains 90 capsules.*

FDA Label Image

Diltiazem-300-mg-cartons.jpg (Diltiazem 300 mg Cartons)

FDA Label Image

Diltiazem-360-mg-30.jpg (Diltiazem 360 mg 30)

This is a description of a medication package of Diltiazem Hydrochloride extended-release capsules. Each capsule contains 360 mg of Diltiazem Hydrochloride. The capsules are for once-a-day dosage and come in a packaging of 30 capsules. The medication should be stored at a temperature of 20° to 25°C, with excursions permitted between 15° to 30°C, and with caution to avoid excessive humidity. The product is manufactured by Macleods Pharma USA, Inc. with a warning to keep the capsules out of reach of children.*

FDA Label Image

Diltiazem-360-mg-90.jpg (Diltiazem 360 mg 90)

This text appears to be a description of Diltiazem Hydrochloride Capsules, USP manufactured by Macleods Pharma USA. The capsules contain 360 mg Diltiazem Hydrochloride, with dosing information included. It is recommended to refer to the package insert for prescribing details. The medication is in extended-release form and should be kept out of reach of children. Storage instructions specify a temperature range and caution against excessive humidity. The product is made by Macleods Pharmaceuticals in India and distributed by Macleods Pharma USA in Princeton, NJ.*

FDA Label Image

Diltiazem-360-mg-cartons.jpg (Diltiazem 360 mg Cartons)

FDA Label Image

Diltiazem-structure.jpg (Diltiazem Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.